Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. (6NQ) Income Statement

Last quarter (Q3 2024), Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.'s total revenue was zł13.41M, an increase of 65.45% from the same quarter last year. In Q3, Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.'s net income was zł-444.00K. See Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.’s key income statements, including revenue, expenses, profit, and income.